Saturday, December 6, 2025

Life Sciences

spot_imgspot_img

Bayer and Aignostics to collaborate on next generation precision oncology

Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics...

Zephyr AI Raises $111 Million in Series A Financing

Latest Investment Will Support the Democratization of Precision Medicine Through the Advancement of Novel Explainable AI Algorithms Zephyr AI, Inc., a healthcare technology company committed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img